A recent study published in PubMed evaluates the comparative effectiveness of tocilizumab versus tumor necrosis factor inhibitors in treating Takayasu arteritis, highlighting age-related differences in treatment response. This research could inform treatment strategies for this rare vascular condition.
comparative effectiveness of tocilizumab and tumor necrosis factor inhibitors in takayasu arteritis age related differences in treatment response
Original title: “Comparative Effectiveness of Tocilizumab and Tumor Necrosis Factor Inhibitors in Takayasu Arteritis: Age-Related Differences in Treatment Response.”